CA 19-9 and CEA in prognosis of duodenal adenocarcinoma: A retrospective study
“To our knowledge, there are no studies evaluating the prognostic importance of CEA and Ca 19-9 in patients with DA [duodenal adenocarcinoma].”
BUFFALO, NY- April 18, 2023 – A new research paper was published in Oncotarget's Volume 14 on April 15, 2023, entitled, “Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.”
Duodenal adenocarcinoma (DA) is a rare ...
















